Infographic: Sharing COVID-19 Vaccine Facts
This iREACH infographic describes three different kinds of false information and explains how to fact check information.
The Power of Cultural Validation – Frontier and Beaches VAC Presentation
At the Frontier and Beaches VAC meetings, Julissa Soto, an independent health equity consultant, presented on the power of cultural validation for immigrants and refugees.
Moderna Half Dose Boosters – What We Know So Far
AIM Members - Please see a quick summary from our Data Project Manager Kristy Westfall on what we know so far regarding the implementation and tracking of Moderna half-dose boosters:…
FAQs on Flu Disease
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
AIM: Fertility, Pregnancy, and COVID-19 Vaccines Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
COVID-19 Vaccine Ingredients and Safety Powerpoint Presentation Template
Help your community learn more about ingredients commonly found in vaccines and the vaccine safety system in the U.S. with this customizable presentation.
COVID-19 Omicron (B.1.1.529) Variant
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.
2024 Immunization Champion Award Winners
Announcing the 2024 Immunization Champions award winners! Please read through to learn more about the 2024 Champions from various jurisdictions.
2023 AIM Leadership in Action Conference
These slide decks and accompanying resources were presented at the 2023 AIM Leadership in Action Conference. Scroll to find presentations from leadership trainings, breakouts, award winners, and more! For any…
Updated COVID-19 Vaccine Booster Doses
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.